Shandong Pharmaceutical Glass Co.Ltd (SHA: 600529)
China
· Delayed Price · Currency is CNY 25.24
-0.02 (-0.08%)
Nov 20, 2024, 10:27 AM CST
Shandong Pharmaceutical Glass Co.Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 882 | 775.8 | 618.29 | 591.09 | 564.44 | 458.69 | Upgrade
|
| Depreciation & Amortization | 324.76 | 324.76 | 295.17 | 240.64 | 217.9 | 169.1 | Upgrade
|
| Other Amortization | 0.37 | 0.37 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 5.73 | 5.73 | -4.53 | -0.59 | 0.13 | -3.49 | Upgrade
|
| Asset Writedown & Restructuring Costs | 48.82 | 48.82 | 48.25 | 61.43 | 65.56 | 57.69 | Upgrade
|
| Loss (Gain) From Sale of Investments | -41.23 | -41.23 | -5.45 | -12.81 | -16.41 | -30.96 | Upgrade
|
| Provision & Write-off of Bad Debts | 11.42 | 11.42 | 12 | 10.87 | 13.33 | 2.6 | Upgrade
|
| Other Operating Activities | -30.12 | -9.62 | -22.23 | 6.25 | 14.88 | -6.12 | Upgrade
|
| Change in Accounts Receivable | -191.12 | -191.12 | -242.64 | -265.71 | -316.8 | -48.06 | Upgrade
|
| Change in Inventory | 125.87 | 125.87 | -355.41 | -155.06 | -99.5 | -121.93 | Upgrade
|
| Change in Accounts Payable | 6.88 | 6.88 | -100.67 | 275.3 | 124.76 | 106.44 | Upgrade
|
| Change in Other Net Operating Assets | -3.89 | -3.89 | 9.26 | 1.82 | 2.16 | 10.87 | Upgrade
|
| Operating Cash Flow | 1,134 | 1,048 | 252.44 | 750.44 | 566.01 | 599.05 | Upgrade
|
| Operating Cash Flow Growth | 45.22% | 315.14% | -66.36% | 32.58% | -5.52% | 28.61% | Upgrade
|
| Capital Expenditures | -537.38 | -671.53 | -710.71 | -809.26 | -535.2 | -591.69 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.51 | 2.21 | 11.18 | 3.45 | 1.42 | 6.11 | Upgrade
|
| Investment in Securities | -390 | -112 | -796 | -74 | 230 | 328 | Upgrade
|
| Other Investing Activities | 38.61 | 36.76 | 7.15 | 12.56 | 17.74 | 29.12 | Upgrade
|
| Investing Cash Flow | -886.26 | -744.57 | -1,488 | -867.25 | -286.04 | -228.46 | Upgrade
|
| Short-Term Debt Issued | - | 12.46 | 5.16 | - | - | - | Upgrade
|
| Total Debt Issued | 12.46 | 12.46 | 5.16 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 12.46 | 12.46 | 5.16 | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 1,842 | - | - | - | Upgrade
|
| Common Dividends Paid | -265.45 | -199.08 | -178.49 | -178.49 | -178.49 | -127.49 | Upgrade
|
| Other Financing Activities | -11.05 | - | -0.96 | - | - | 0.12 | Upgrade
|
| Financing Cash Flow | -264.03 | -186.62 | 1,668 | -178.49 | -178.49 | -127.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11.85 | 9.69 | 20.19 | -6.64 | -14.88 | 5.99 | Upgrade
|
| Net Cash Flow | -4.77 | 126.48 | 452.42 | -301.94 | 86.6 | 249.22 | Upgrade
|
| Free Cash Flow | 596.3 | 376.45 | -458.27 | -58.82 | 30.81 | 7.36 | Upgrade
|
| Free Cash Flow Growth | 626.18% | - | - | - | 318.43% | -93.78% | Upgrade
|
| Free Cash Flow Margin | 11.62% | 7.56% | -10.94% | -1.52% | 0.90% | 0.25% | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.57 | -0.76 | -0.10 | 0.05 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 290.45 | 252.97 | 137.17 | 166.19 | 80.16 | 83.05 | Upgrade
|
| Levered Free Cash Flow | 693.87 | 156.21 | -646.81 | -132.14 | -151.53 | -18.26 | Upgrade
|
| Unlevered Free Cash Flow | 693.91 | 156.36 | -646.64 | -131.96 | -151.46 | -17.72 | Upgrade
|
| Change in Net Working Capital | -277.96 | 27.6 | 645.45 | -12.66 | 247.51 | -75.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.